OJOG  Vol.3 No.7 A , September 2013
Benign ovarian cysts in reproductive-age women undergoing assisted reproductive technology treatment
ABSTRACT

The scope of this review is to focus on the management of benign ovarian cyst in the reproductive-age group of women undergoing ART. Ovarian cysts are a common occurrence in this patient population. The differential diagnosis includes functional cysts, dermoid cysts, endometrioma. The appropriate evaluation includes medical history and physical examination, laboratory tests and imaging. The treatment options include conservative follow-up, medical treatment and surgery. This review will explore the differential diagnosis, appropriate work-up and treatment options to the various cyst types encountered.


Cite this paper
Rofe, G. , Auslender, R. and Dirnfeld, M. (2013) Benign ovarian cysts in reproductive-age women undergoing assisted reproductive technology treatment. Open Journal of Obstetrics and Gynecology, 3, 17-22. doi: 10.4236/ojog.2013.37A1005.
References
[1]   Helm, C.W. (2012) Ovarian Cysts, Medscape. http://emedicine.medscape.com/article/255865-overview#showall

[2]   ACOG Practice Bulletin (2007) Management of adnexal masses. Obstetrics and Gynecology, 110, 201-214.

[3]   Teichmann, A.T., et al. (1995) The influence of the dose of ethinylestradiol in oral contraceptives on follicle growth. Gynecological endocrinology: The Official Journal of the International Society of Gynecological Endocrinology, 9, 299-305. doi:10.3109/09513599509160463

[4]   Qublan, H.S., et al. (2006) Ovarian cyst formation following GnRH agonist administration in IVF cycles: Incidence and impact. Human reproduction, 21, 640-644. doi:10.1093/humrep/dei371

[5]   Nelson-Al, G.J. (2010) Congenital anomalies and benign conditions of the ovaries and fallopian tubes. In: Hacker, N.F., Gambone, J.C. and Hobel, C.J., Eds., Hacker and Moore’s Essentials of Obstetrics and Gynecology, 5th Edition, Saunders, Philadelphia, 248-255.

[6]   Beckmann, L.F. and Smith, R.P., et al. (2006) Ovarian and adnexal disease. In: Beckmann C.R.B., Ling F.W., Smith R.P., et al, Eds., Obstetrics and Gynecology, 5th Edition, Lippincott Williams & Wilkins, Philadelphia, 464-476.

[7]   Rossing, M.A., et al. (1994) Ovarian tumors in a cohort of infertile women. The New England Journal of Medicine, 331, 771-776. doi:10.1056/NEJM199409223311204

[8]   Koonings, P.P., Campbell, K., Mishell, D.R. Jr. and Grimes, D.A. (1989) Relative frequency of primary ovarian neoplasms: A 10-year review. Obstet Gynecol, 74, 921-926.

[9]   Ayhan, A.B.O., Genc, C., Karamursel, B.S. and Ayhan, A. (2000) Mature cystic teratomas of the ovary: Case series from one institution over 34 years. European Journal of Obstetrics & Gynecology and Reproductive, 88, 153-157. doi:10.1016/S0301-2115(99)00141-4

[10]   Caspi, B., et al. (1997) The growth pattern of ovarian dermoid cysts: A prospective study in premenopausal and postmenopausal women. Fertility and Sterility, 68, 501-505. doi:10.1016/S0015-0282(97)00228-8

[11]   Hoo, W.L., et al. (2010) Expectant management of ultrasonically diagnosed ovarian dermoid cysts: Is it possible to predict outcome? Ultrasound in obstetrics & gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 36, 235-240. doi:10.1002/ uog.7610

[12]   O’Neill, K.E. and Cooper, A.R. (2011) The approach to ovarian dermoids in adolescents and young women. Journal of Pediatric and Adolescent Gynecology, 24, 176-180. doi:10.1016/j.jpag. 2010.11.006

[13]   Gelbaya, T.A., et al. (2010) Management of endometrioma prior to IVF: Compliance with ESHRE guidelines. Reproductive Biomedicine Online, 21, 325-330. doi:10.1016/j.rbmo.2010.04.023

[14]   ESHRE (2013) Management of women with endomertiosis. In press.

[15]   Surrey, E.S. (2013) Endometriosis and assisted reproducetive technologies: Maximizing outcomes. Seminars in Reproductive Medicine, 31, 154-163.

[16]   Tsoumpou, I., et al. (2009) The effect of surgical treatment for endometrioma on in vitro fertilization outcomes: A systematic review and meta-analysis. Fertility and Sterility, 92, 75-87. doi:10.1016/ j.fertnstert.2008.05.049

[17]   D.O.H.L.D. (2009) Key messages for ovarian cancer for health professionals.

[18]   Ueland, F.R., et al. (2005) The accuracy of examination under anesthesia and transvaginal sonography in evaluating ovarian size. Gynecologic Oncology, 99, 400-403. doi:10.1016/ j.ygyno.2005.06.030

[19]   Ballard, K.D., et al. (2008) Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study—Part 1. International Journal of Obstetrics and Gynaecology, 115, 1382-1391. doi:10.1111/j.1471-0528.2008.01878.x

[20]   Padilla, L.A., Radosevich, D.M. and Milad, M.P. (2000) Accuracy of the pelvic examination in detecting adnexal masses. Obstetrics and Gynecology, 96, 593-598. doi:10.1016/S0029-7844(00)00970-4

[21]   Kahraman, K., et al. (2007) Extremely elevated serum CA-125 level as a result of unruptured unilateral endometrioma: The highest value reported. Fertility and sterility, 88, e15-e17. doi:10.1016/j.fertnstert.2006.12.076

[22]   Zurawski, V.R., Jr., et al. (1988) Elevated serum CA 125 levels prior to diagnosis of ovarian neoplasia: Relevance for early detection of ovarian cancer. International Journal of Cancer, 42, 677-680. doi:10.1002/ijc.2910420507

[23]   Van Calster, B., et al. (2007) Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. Journal of the National Cancer Institute, 99, 1706-1714. doi:10.1093/jnci/djm199

[24]   Im, S.S., et al. (2005) Validation of referral guidelines for women with pelvic masses. Obstetrics and Gynecology, 105, 35-41. doi:10.1097/01.AOG.0000149159.69560.ef

[25]   Timmerman, D., et al. (2007) Inclusion of CA-125 does not improve mathematical models developed to distinguish between benign and malignant adnexal tumors. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 25, 4194-200.

[26]   Timmerman, D., et al. (2008) Simple ultrasound-based rules for the diagnosis of ovarian cancer. Ultrasound in obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 31, 681-690. doi:10.1002/uog.5365

[27]   Broekmans, F.J., et al. (2006) A systematic review of tests predicting ovarian reserve and IVF outcome. Human Reproduction Update, 12, 685-718. doi:10.1093/humupd/dml034

[28]   De Vet, A., et al. (2002) Antimullerian hormone serum levels: A putative marker for ovarian aging. Fertility and Sterility, 77, 357-362. doi:10.1016/S0015-0282(01)02993-4

[29]   Gnoth, C., et al. (2008) Relevance of anti-Mullerian hormone measurement in a routine IVF program. Human Reproduction, 23, 1359-1365. doi:10.1093/humrep/den108

[30]   Van Rooij, I.A., et al. (2005) Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: A longitudinal study. Fertility and Sterility, 83, 979-987. doi:10.1016/j.fertnstert.2004.11.029

[31]   Almog, B., et al. (2011) Age-related normograms of serum antimullerian hormone levels in a population of infertile women: A multicenter study. Fertility and Sterility, 95, 2359-2363. doi:10.1016/j.fertnstert.2011.02.057

[32]   Timmerman, D., et al. (1999) Subjective assessment of adnexal masses with the use of ultrasonography: An analysis of interobserver variability and experience. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 13, 11-16. doi:10.1046/j.1469-0705.1999.13010011.x

[33]   Patel, M.D., et al. (1998) Cystic teratomas of the ovary: Diagnostic value of sonography. American Journal of Roentgenology, 171, 1061-1065. doi:10.2214/ajr.171.4.9762997

[34]   Van Holsbeke, C., et al. (2010) Endometriomas: Their ultrasound characteristics. Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology, 35, 730-740.

[35]   Sassone, A.M., et al. (1991) Transvaginal sonographic characterization of ovarian disease: Evaluation of a new scoring system to predict ovarian malignancy. Obstetrics and Gynecology, 78, 70-76.

[36]   Vuento, M.H., et al. (1995) Evaluation of ovarian findings in asymptomatic postmenopausal women with color doppler ultrasound. Cancer, 76, 1214-1218. doi:10.1002/1097-0142(19951001)76:7<1214::AID-CNCR2820760718>3.0.CO;2-5

[37]   Stein, S.M., et al. (1995) Differentiation of benign and malignant adnexal masses: Relative value of gray-scale, color doppler, and spectral doppler sonography. American Journal of Roentgenology, 164, 381-386. doi:10.2214/ajr.164.2.7839975

[38]   Dai, S.Y., et al. (2008) Does three-dimensional power doppler ultrasound improve the diagnostic accuracy for the prediction of adnexal malignancy? The Journal of Obstetrics and Gynaecology Research, 34, 364-370. doi:10.1111/j.1447-0756.2007.00702.x

[39]   Guerriero, S., et al. (2007) Three-dimensional quantification of tumor vascularity as a tertiary test after B-mode and power doppler evaluation for detection of ovarian cancer. Journal of Ultrasound in Medicine, 26, 1271-1278.

[40]   MacKenna, A., et al. (2000) Clinical management of functional ovarian cysts: A prospective and randomized study. Human Reproduction, 15, 2567-2569. doi:10.1093/humrep/15.12.2567

[41]   Levine, D., et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of radiologists in ultrasound consensus conference statement. Ultrasound Quarterly, 26, 121-131. doi:10.1097/RUQ.0b013e3181f09099

[42]   Katz, L., et al. (2010) Pregnancy outcome of patients with dermoid and other benign ovarian cysts. Archives of Gynecology and Obstetrics, 281, 811-815. doi:10.1007/s00404-009-1158-1

[43]   Grimes, D.A., et al. (2009) Oral contraceptives for functional ovarian cysts. The Cochrane Database of Systematic Reviews, 2, Article ID: CD006134.

[44]   Karen P. and James E.W. (2002) In benign disorders of the ovaries & oviducts. Current Obstetrics & Gynecologic diagnosis & treatment, 9th Edition, McGrak Hill, pp. 708-715.

[45]   Holt, V.L., Cushing-Haugen, K.L. and Daling, J.R. (2003) Oral contraceptives, tubal sterilization, and functional ovarian cyst risk. Obstetrics and Gynecology, 102, 252-258. doi:10.1016/S0029-7844(03)00572-6

[46]   Kim, S.H., et al. (2013) Update on the treatment of endometriosis. Clinical and Experimental Reproductive Medicine, 40, 55-59. doi:10.5653/cerm.2013.40.2.55

[47]   Raffi, F., Shaw, R.W. and Amer, S.A. (2012) National survey of the current management of endometriomas in women undergoing assisted reproductive treatment. Human Reproduction, 27, 2712-2719. doi:10.1093/humrep/des195

[48]   Tavmergen, E., Ulukus, M. and Goker, E.N. (2007) Long-term use of gonadotropin-releasing hormone analogues before IVF in women with endometriosis. Current Opinion in Obstetrics & Gynecology, 19, 284-288. doi:10.1097/GCO.0b013e3281053a52

[49]   Surrey, E.S., et al. (2002) Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertility and Sterility, 78, 699-704. doi:10.1016/S0015-0282(02)03373-3

[50]   Ben-Ami, M., et al. (1993) Management of functional ovarian cysts after induction of ovulation. A randomized prospective study. Acta Obstetricia et Gynecologica Scandinavica, 72, 396-397. doi:10.3109/00016349309021121

[51]   Steinkampf, M.P., Hammond, K.R. and Blackwell, R.E. (1990) Hormonal treatment of functional ovarian cysts: A randomized, prospective study. Fertility and Sterility, 54, 775-777.

[52]   Turan, C., et al. (1994) Expectant management of functional ovarian cysts: An alternative to hormonal therapy. International Journal of Gynaecology and Obstetrics, 47, 257-260. doi:10.1016/ 0020-7292(94)90570-3

[53]   Alcazar, J.L., et al. (2005) Is expectant management of sonographically benign adnexal cysts an option in selected asymptomatic premenopausal women? Human Reproduction, 20, 3231-3234.

[54]   Mais, V., et al. (2003) No recurrence of mature ovarian teratomas after laparoscopic cystectomy. BJOG: An International Journal of Obstetrics and Gynaecology, 110, 624-626. doi:10.1046/j.1471-0528.2003.02040.x

[55]   Yuen, P.M., et al. (1997) A randomized prospective study of laparoscopy and laparotomy in the management of benign ovarian masses. American Journal of Obstetrics and Gynecology, 177, 109-114. doi:10.1016/S0002-9378(97)70447-2

[56]   Panici, P.B., et al. (2007) Minilaparotomy versus laparoscopy in the treatment of benign adnexal cysts: A randomized clinical study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 133, 218-222. doi:10.1016/j.ejogrb.2006.05.019

[57]   Fanfani, F., et al. (2004) A prospective randomized study of laparoscopy and minilaparotomy in the management of benign adnexal masses. Human Reproduction, 19, 2367-2371. doi:10.1093/ humrep/deh413

[58]   Medeiros, L.R., et al. (2008) Laparoscopy versus laparotomy for benign ovarian tumor: A systematic review and meta-analysis. International Journal of Gynecological Cancer, 18, 387-399.

[59]   Garcea, N., et al. (1996) Surgical treatment of ovarian cysts: Economic analysis as a means for the evaluation of alternative technics. Results of a biennial study. Minerva Ginecologica, 48, 77-83.

[60]   Zanetta, G., et al. (1996) Role of puncture and aspiration in expectant management of simple ovarian cysts: A randomised study. British Medical Journal, 313, 1110-1113. doi:10.1136/ bmj.313.7065.1110

[61]   Marana, R., et al. (1996) Operative laparoscopy for ovarian cysts. Excision vs. aspiration. The Journal of Reproductive Medicine, 41, 435-438.

 
 
Top